| Application no. and date | 19832737.1 (espacenet) (Federated) (European Patent Register), 20191213 | | Patent/reg. no. and date | DK/EP 3893924, 20240821 | | Publication date | 20211020 | | Priority no. and date | US 201862779102 P, 20181213 | | EP pub. no. and date |
EP 3893924 20211020 | | Effective date | | | Applicant/owner | argenx BV, Industriepark 7
9052 Zwijnaarde, BE | | Applicant ref. no. | 6.2409.006 | | Inventor | BLANCHETOT, Christophe, Volderrede 49
9070 Destelbergen, BE,
DE HAARD, Hans, t'Zwint, 1
NA 4436 Oudelande, NL | | Representative | Holme Patent A/S, Valbygårdsvej 33, 1, 2500 Valby, DK | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 35/02 (2006.01) , A61P 37/06 (2006.01) , C07K 14/435 (2006.01) , C07K 16/18 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) | | Title | Antistoffer til human komplementfaktor C2B og anvendelsesfremgangsmåder | | Int. application no. | IB2019060802 | | Int. publication no. | WO2020121282 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
